ストックスクリーナーアプリを入手
7.44
1.78%
0.13
前日終値:
$7.31
開ける：
$7.48
24時間の取引高:
6,888
Relative Volume:
0.10
時価総額：
$172.93M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.49%
1か月 パフォーマンス:
+15.17%
6か月 パフォーマンス:
-18.15%
1年 パフォーマンス:
-15.07%
1日の値動き範囲:
$7.41
$7.635
1週間の範囲:
$7.05
$7.635
52週間の値動き範囲:
$5.47
$11.99
Actuate Therapeutics Inc Stock (ACTU) Company Profile
ACTU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACTU
Actuate Therapeutics Inc
|
7.44 | 170.84M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.95 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
730.00 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.48 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.91 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.33 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-26 | 開始されました | B. Riley Securities | Buy |
| 2025-04-22 | 開始されました | Craig Hallum | Buy |
| 2025-03-17 | 開始されました | H.C. Wainwright | Buy |
Actuate Therapeutics Inc (ACTU) 最新ニュース
Will Actuate Therapeutics Inc. stock see PE expansionInsider Selling & Daily Chart Pattern Signal Reports - Newser
Why Actuate Therapeutics Inc. stock is a must watch in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Actuate Therapeutics enters $100 million at-the-market sales agreement - Investing.com
Actuate Therapeutics Signs $100M Sales Agreement - TipRanks
Actuate Therapeutics Inc enters at the market issuance sales agreement with B. Riley and Craig-HallumSEC filing - marketscreener.com
How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06% - Zacks Investment Research
Why Actuate Therapeutics Inc. stock is recommended by analystsJuly 2025 Analyst Calls & Verified Technical Trade Signals - BỘ NỘI VỤ
What risks investors should watch in Actuate Therapeutics Inc. stockOptions Play & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Actuate Therapeutics, Inc.'s (NASDAQ:ACTU) market cap surged US$24m last week, private equity firms who have a lot riding on the company were rewarded - simplywall.st
BIOS Capital Management LP Buys 71,428 Shares of Actuate Therapeutics, Inc. $ACTU - Defense World
What analysts say about Actuate Therapeutics Inc stockTrade Execution Strategies & Daily Tips From Top Market Analysts - earlytimes.in
Will Upside Catalysts Materialize for Prime Industries Limited in YEARHigh Frequency Trading Trends & Free Unlock Rapid Growth Potential - earlytimes.in
HC Wainwright Has Bullish Estimate for ACTU FY2025 Earnings - Defense World
Why Actuate Therapeutics Inc. stock is in analyst buy zoneEarnings Trend Report & Verified Entry Point Signals - newser.com
Actuate Therapeutics: Strategic Advancements and Financial Outlook Drive Buy Rating - TipRanks
HC Wainwright & Co. Reiterates Actuate Therapeutics (ACTU) Buy Recommendation - Nasdaq
How Actuate Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Expert Approved Momentum Ideas - newser.com
Using R and stats models for Actuate Therapeutics Inc. forecastingRate Hike & Fast Gaining Stock Reports - newser.com
Strategies to average down on Actuate Therapeutics Inc.Quarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
How Actuate Therapeutics Inc. stock benefits from tech adoptionTrade Volume Summary & Long-Term Growth Plans - newser.com
Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Is it time to cut losses on Actuate Therapeutics Inc.July 2025 Update & High Yield Stock Recommendations - newser.com
Here's Why We're Watching Actuate Therapeutics' (NASDAQ:ACTU) Cash Burn Situation - Yahoo Finance
What indicators show strength in Actuate Therapeutics Inc.July 2025 Decliners & Advanced Technical Signal Analysis - newser.com
Actuate Therapeutics (NASDAQ:ACTU) Stock Price Up 0.5% on Better-Than-Expected Earnings - Defense World
Analysts Offer Insights on Healthcare Companies: Vicarious Surgical (RBOT) and Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Actuate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA), Janux Therapeutics Inc (JANX) and Eledon Pharmaceuticals (ELDN) - The Globe and Mail
What’s next for Actuate Therapeutics Inc. stock priceJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Real time scanner hits for Actuate Therapeutics Inc. explained2025 Sector Review & Precise Swing Trade Alerts - newser.com
Is Actuate Therapeutics Inc. building a consolidation base2025 Trading Recap & AI Forecast for Swing Trade Picks - newser.com
Myelofibrosis Market is Expected to Flourish in 7MM, Expanding - openPR.com
Actuate Therapeutics Inc (ACTU) 財務データ
Actuate Therapeutics Inc (ACTU) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.14%
0.18%
大文字化:
|
ボリューム (24 時間):